REVIEW
Accepted on 07 Apr 2025
ICI-induced Cardiovascular Toxicity: Mechanisms and Immune Reprogramming Therapeutic Strategies
doi 10.3389/fimmu.2025.1550400
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
4,922
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 28 Mar 2025
Revealing the Mechanisms and Therapeutic Potential of Immune Checkpoint Proteins Across Diverse Protein Families
doi 10.3389/fimmu.2025.1499663
SYSTEMATIC REVIEW
Published on 26 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1563300
- 313 views
CASE REPORT
Published on 24 Mar 2025
Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings
doi 10.3389/fimmu.2025.1543114
- 406 views
SYSTEMATIC REVIEW
Published on 11 Mar 2025
Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1542850
- 412 views
ORIGINAL RESEARCH
Published on 07 Feb 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity
doi 10.3389/fimmu.2025.1534936
- 1,157 views
OPINION
Published on 10 Dec 2024
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
doi 10.3389/fimmu.2024.1490129
- 919 views
- 4 citations
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
doi 10.3389/fimmu.2024.1482746
- 1,339 views
- 2 citations
REVIEW
Published on 04 Oct 2024
Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment
doi 10.3389/fimmu.2024.1441667
- 2,248 views
- 3 citations
SYSTEMATIC REVIEW
Published on 01 Oct 2024
Efficacy and safety of immune checkpoint inhibitors as neoadjuvant therapy in perioperative patients with non-small cell lung cancer: a network meta-analysis and systematic review based on randomized controlled trials
doi 10.3389/fimmu.2024.1432813
- 2,154 views
- 2 citations
OPINION
Published on 12 Jul 2024
Microbiota-metabolism-epigenetics-immunity axis in cancer
doi 10.3389/fimmu.2024.1449912
- 1,480 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: